• Treeline Biosciences

  Participated · Series A · Sep 2025

  Treeline is a clinical-stage biopharma focused on developing medicines for cancer and other serious diseases using internal R&D and leading-edge computational tools. Its pipeline includes small molecules, protein degraders and glues, and targeted therapy ADCs (TT‑ADCs). The company has initiated Phase 1 trials for three programs: TLN-121 (a BCL6 degrader for lymphomas), TLN-372 (a pan‑KRAS inhibitor for KRAS‑altered solid tumors), and TLN-254 (an in-licensed EZH2 inhibitor for T‑cell lymphomas). Treeline’s team and pipeline were built for scaled invention and company longevity and are led by co-founders Josh Bilenker, M.D., and Jeff Engelman. Therapeutic focus spans oncology with efforts also in neurological and autoimmune diseases. Financially, Treeline is privately held and has raised $1.1 billion to date, reflecting substantial capital to advance its clinical programs.

• Volteras

  Participated · Series A · May 2025

  Volteras builds virtual connective tissue that lets plugged-in EVs offer battery capacity back to the grid while exposing connected-car features such as remote unlocking and telematics. The company integrates with automakers’ APIs and sells those functions to other businesses. It charges corporate customers a monthly fee per connected car and passes a portion of that revenue to automakers. Aggregated cars can operate as virtual power plants, giving utilities quickly dispatchable distributed power. Volteras says it works with more than 30 automakers, including Ford, BMW, Tesla, Stellantis and Volvo, and aims to cover roughly 90% of the automotive market worldwide by the end of the year. The startup is pursuing customers such as utilities, fleet managers, EV routing apps and insurers to unlock usage-based services and new revenue streams. Volteras builds an API platform that aims to be the connective tissue between EVs and the surrounding energy and charging ecosystem, linking cars, chargers, home batteries, retailers and mapping apps. The company charges OEMs and energy retailers for API access while promising not to harvest or sell user data. Volteras says its platform enables utilities and retailers to perform functions such as load balancing and optimized charging when customers opt in. The startup has partnered or hooked up with OEMs and energy firms including Mercedes, BMW, Volvo and Enphase. Volteras has operated under the radar for about three years and is led by founder and CEO Peter Wilson. Financially, it closed a roughly $2.9M seed round valued at around $12M.

• Proton

  Participated · Seed · Dec 2024

  Proton is developing a small device designed to be inserted just below the skin to continuously monitor potassium levels and pair with a smartphone app for patient alerts. A clinician dashboard is planned so care teams can view potassium trends and fine-tune therapies, potentially reducing in-clinic potassium testing, time, and costs. The company targets patients with chronic kidney disease and those at risk of heart failure, where potassium imbalances can be life‑threatening. Clinical trials are underway for the product, which Proton says is due to launch in 2025. The founders are CEO Sahan Ranamukhaarachchi (based in Vancouver) and CSO Victor Cadarso (based in Melbourne); the company has a commercial HQ in Canada and an R&D subsidiary in Melbourne, Australia. Proton positions its approach against other emerging potassium-monitoring firms and claims greater scalability, usability, and clinical impact.

• Cowboy

  Participated · Equity · Sep 2024

  Cowboy is a Brussels-based e-bike manufacturer best known for its digitally connected urban bicycles that integrate proprietary software, data-driven features and over-the-air updates. The company serves a community of more than 80,000 riders and maintains in-house design, engineering and software teams to iterate on its award-winning hardware-software platform. Following recent operational challenges, Cowboy is partnering with French mobility group ReBirth to leverage its industrial capacity, supply-chain reach and 95 Oxygen/10 Ovelo stores plus 500 independent dealers in France. Production will restart at ReBirth’s French assembly site with a plan to build over 1,500 bikes in January and significantly scale capacity through 2026. The integration is expected to shorten lead times, improve quality control and bolster after-sales support while keeping Cowboy’s brand and R&D independent. Financially, the company has restructured its balance sheet, converted legacy obligations to equity, and secured fresh funding to stabilise operations. These measures aim to restore delivery reliability, expand retail presence—especially in France, currently its fourth-largest market—and move the business toward sustainable profitability.

• Bee

  Led · Seed · Aug 2024

  Bee is a San Francisco-based startup led by Maria de Lourdes Zollo that is developing a life-admin wearable assistant. Its core product is a Bluetooth device about the size of an AirTag with a microphone that captures users’ daily life to perform tasks and make personalized suggestions. Bee also offers Apple Watch recording functionality and a cloud-based phone that can act across popular apps to perform actions with minimal guidance. The device learns preferences, habits, and priorities over time and Bees can communicate with each other to help manage relationships on users’ behalf. Bee uses signals such as location, time use, and voice characteristics to generate personalized reminders, appointments, and activity suggestions. The company plans a Fall 2024 launch and will use the funding to expand operations and development efforts. It raised $7M in seed funding to support those plans.

No current team members are available.